Dental Practice EBITDA Multiples in 2026

If you search this question, you will get answers between roughly 2.5 and 14. That spread is not a disagreement about the market.

It is several different questions being answered as though they were one.

Some of those figures describe a small owner-operated practice bought as a tuck-in. Some describe a multi-site group with real management infrastructure.

At least a few are revenue multiples wearing an EBITDA label.

So before anything else: a multiple only means something once you know what size practice and what kind of buyer it refers to.

Key takeaways

• Multiples scale with size, sharply. The gap between a small tuck-in and a platform-scale group is not a point or two. It can be double.
• Published figures conflict because they describe different things. Check the practice size and the measurement before you apply any number to yourself.
• The multiple is partly a function of your process. A single buyer negotiating against nobody prices differently from four who know the others exist.
• A single multiplier point is real money. On $800,000 of adjusted EBITDA, one more point is $800,000 of enterprise value.
• Buyer-specific multiples are not publishable. Any source telling you exactly what a named DSO pays is guessing or generalizing from one deal.

What is a typical dental practice EBITDA multiple in 2026? Multiples scale with practice size and buyer type. Smaller single-location practices acquired as tuck-ins sit in the low-to-mid single digits.

Two-to-four-doctor groups sit higher. Multi-location regional groups and platform-scale groups with substantial EBITDA reach the low double digits.

There is no single market multiple.

What a multiple actually is

The multiple is the multiplier applied to your earnings. A buyer takes your adjusted EBITDA, multiplies it by the multiple, and that is the enterprise value.

Adjusted EBITDA is what the practice earns in pure operating profit after paying a market-rate dentist to do the work you currently do yourself, and after adding back genuine one-time or personal expenses.

A multiplier point is one whole number of multiple. Moving from 6x to 8x is two points.

On $800,000 of adjusted EBITDA that is $1.6 million of additional enterprise value.

That arithmetic is why this question gets asked so often, and why getting it wrong is expensive.

The ranges, hedged honestly

The credible 2026 ranges cluster by size band. Sources vary and any individual deal can fall outside these, so treat them as the shape of the market rather than a quote.

Practice profile	Typical buyer treatment	Indicative range
Small single-location, owner-produced	Tuck-in / add-on	Low single digits to ~6x
Well-run single location	Regional add-on	~5x to 7x
2-4 doctor group, associate-led	Regional add-on	~7x to 9x
5-9 location regional group	Emerging platform	~8x to 11x
Platform scale, substantial EBITDA	Platform acquisition	~10x to 14x

Two honest caveats about that table.

First, the low end is where unrepresented owners land. Tuck-in acquisitions negotiated directly, with no competing bidder, close at the bottom of the range routinely. That is not a criticism of the buyers.

It is what happens when there is no competitive pressure.

Second, be skeptical of published figures in the low single digits for general dentistry. Several widely-read pages put general dentistry at 2.5x to 4.0x. Those numbers generally describe very small practices, or they are percentage-of-collections figures converted carelessly.

Applying them to a prepared practice at scale will anchor your expectations far below what the market pays.

Why the size effect is so strong

It looks unfair at first. The same dentistry, the same quality of care, and a group of five practices is worth proportionally more than one practice.

The reason is what the buyer is actually acquiring.

A single practice is a job plus some cash flow. When the owner leaves, the buyer has an integration project, a hiring problem and concentration risk in one location.

A multi-site group with a functioning management layer is an operating company. It has redundancy.

It has people who run it who are not the seller. It can absorb further acquisitions.

And critically, the buyer can often sell it later at a higher multiple than they paid, which is the entire economic logic of consolidation.

That last point is worth understanding, because it explains the market you are selling into. Buyers acquire smaller practices at lower multiples, integrate them, and later sell the combined entity at a higher multiple.

The spread is where their return comes from. None of that is hidden or improper.

But it does mean the multiple you are offered reflects your position in that chain.

What actually moves your multiple

Within your size band, four things move the number consistently.

How much production runs through you. A practice where the owner is the primary producer carries departure risk, and buyers price risk. Associate-led production reduces it.

This is the single most controllable driver for most owners.

Hygiene share. Hygiene above roughly 30% of collections signals recurring, transferable patient revenue. It tends to earn a premium for the same reason.

Payer mix. Fee-for-service and well-negotiated PPO contracts price better than heavy low-reimbursement exposure, because the buyer is modelling forward margin.

Defensibility of the earnings. An EBITDA number that survives the buyer’s accountants intact supports the top of the range. One that gets picked apart during diligence gets re-traded, and a re-trade after you have gone exclusive with one buyer is the worst negotiating position in the process.

And then the factor that sits outside your practice entirely.

The process factor

The market is well capitalized. There are roughly 130 private equity-backed DSOs, the Association of Dental Support Organizations counts 80-plus member companies supporting more than 8,500 practices, and 69% of DSOs reported in 2026 that their sponsors expect increased acquisition activity.

Becker’s tracked 200-plus DSO affiliations in 2025.

That is a lot of buyers. Almost none of them are bidding against each other on any given practice, because most practices are acquired through a direct approach to one owner.

When several vetted buyers know the others are at the table, two things move. The multiple, obviously.

And the terms — how much is cash at close, how long you stay, what your hours look like, whether the earnout targets are actually reachable.

In my experience the terms often matter more than the last half point of multiple, and they are almost entirely a function of competition.

This is what the Elite Selling System is designed to produce. We hand-select and vet every buyer who gets to bid, the way a doorman with a velvet rope lets in only the right people, and run a private competitive window inside that group.

One structural note that surprises owners: regional platforms often outbid national ones inside their own footprint, because filling in a market they already operate in is worth more to them than a scattered addition is to a national buyer.

An owner who only responds to the national group that called them never discovers that.

What one multiplier point is actually worth to you

Abstract multiples are hard to feel. Run them against real numbers and the stakes get obvious fast.

Take three practices. Each is well run.

Each sits in a different size band.

Practice A collects $1.8 million with adjusted EBITDA of $360,000. One multiplier point is $360,000.

Move from 5x to 6x and the owner clears an extra third of a million dollars for the same dentistry, the same building, the same patients.

Practice B collects $4 million across two locations, associate-led, adjusted EBITDA $900,000. One point is $900,000.

The gap between 7x and 9x on that practice is $1.8 million.

Practice C is a five-location group with $2.1 million of adjusted EBITDA. One point is $2.1 million.

The distance between the bottom and top of its band is most of a decade’s income.

Now hold that against what it costs to move a single point.

Getting hygiene from 24% of collections to 32% takes about eighteen months and some genuinely hard hiring. Shifting restorative production from the owner’s hands to an associate’s takes about the same.

Neither is pleasant. Both are cheap next to what a single turn is worth.

I have watched an owner spend six weeks arguing over a $40,000 equipment credit in the purchase agreement while sitting on a practice where one multiplier point was worth $700,000. The equipment credit felt concrete.

The turn felt theoretical. It was not.

The re-trade, which costs more than the multiple

There is one number worse than a low multiple, and it is a good multiple that does not survive to closing.

The sequence is always the same. An owner signs a letter of intent at an attractive figure.

The letter carries exclusivity, so for a defined period they cannot talk to anyone else. The other interested parties go away.

Then diligence starts. The buyer’s accountants rebuild the earnings from source data and find that a portion of the claimed add-backs cannot be evidenced.

Say $150,000 of add-backs get disallowed on a practice being priced at 8x. That is not a $150,000 problem.

It is a $1.2 million problem, because the disallowed EBITDA gets multiplied like everything else.

And at that moment the owner has no leverage. The competing bidders are gone.

Months have passed. Starting over means starting over.

This is why preparation is not administrative housekeeping. An add-back you cannot document is not an add-back.

It is a future price reduction with a delay on it.

Why nobody should tell you what a specific DSO pays

You will find pages claiming a named DSO “typically pays” a specific multiple. Treat those with real caution.

Buyers do not run price sheets. What any group pays depends on the practice, the market, their current appetite, their capital position, and who else is bidding.

A figure attached to a named buyer is either generalized from a single deal or invented.

What can be said honestly is directional: competitive outcomes for strong, well-prepared practices land meaningfully above what the same practice is offered in a direct, single-bidder approach.

That statement holds across the buyer pool rather than singling anyone out, which is also why it is the useful one.

The add-backs worth documenting now

Since add-backs move the multiplied number, it is worth knowing which ones survive scrutiny and which ones get struck out.

Usually accepted, with evidence. A vehicle run through the practice. Family members on payroll above market rate, adjusted down to market.

Owner compensation above what a hired dentist would cost. Genuine one-time legal or consulting fees.

A one-off equipment repair that will not recur. Personal travel or meals coded to the practice.

Usually rejected. Anything you cannot evidence with an invoice or a payroll record. Recurring costs described as one-time.

Marketing you cut last year and called an efficiency. Deferred maintenance, which buyers treat as a liability rather than a saving.

The distinction is documentation, not category. An owner who tells me their spouse’s salary is an add-back has an argument.

An owner who can show the payroll records, the job description and the market rate for that role has a number that survives diligence.

Start the file now. Every month you wait is a month of receipts you will be reconstructing under time pressure while a buyer’s accountant waits.

A note on where multiples are heading

Owners frequently ask whether they should wait for a better market. I am cautious about that question, because it invites guessing.

What can be said is that the capital is present and the demand is structural rather than cyclical.

Roughly 130 private equity-backed groups are active, most report expecting to increase acquisitions, and the underlying driver is a generation of owners approaching retirement against a younger cohort choosing employment. None of that resolves quickly.

What moves against you is time. Every year you wait is a year closer to the point where you need to sell rather than choose to, and need is the most expensive position in any negotiation.

What to do with this

If you are trying to work out whether an offer is any good, do it in this order.

Convert the offer to a multiple of your adjusted EBITDA. If it is quoted as a percentage of collections, that conversion is mandatory, not optional.

Separate the cash at close from rollover equity and earnout, because those are not the same asset. Then place the result against the right size band, not against a headline number written about a practice five times your size.

If it lands at the bottom of your band, that is not necessarily a bad-faith offer. It is usually just an uncontested one.

We will look at your numbers and tell you where you actually sit, including when the honest answer is that your multiple would be higher in two years than it is today. Start with a free, confidential practice value estimate.

Our fee varies depending on the value of the practice and is success-based. If we do not get you a result, we do not get paid.

---

Frequently asked questions

What is a typical EBITDA multiple for a dental practice in 2026?

There is no single figure. Multiples scale with size: smaller single-location practices bought as tuck-ins sit in the low-to-mid single digits, two-to-four-doctor groups higher, regional multi-location groups higher again, and platform-scale groups with substantial EBITDA reach the low double digits.

Why do published dental EBITDA multiples vary so much?

Because they describe different practices and sometimes different measurements. Figures in the low single digits usually refer to very small practices, or are revenue multiples mislabeled as EBITDA multiples.

Always check what size and what metric a published number refers to.

What is a multiplier point, and why does it matter?

A multiplier point is one whole number of multiple. Moving from 6x to 7x is one point.

On $800,000 of adjusted EBITDA that single point is $800,000 of additional enterprise value, which is why small movements in the multiple matter more than most owners expect.

Does a bigger practice really get a higher multiple?

Yes, consistently. A larger group has management depth, redundancy and lower dependence on any one person, and the buyer can often resell the integrated entity at a higher multiple than they paid.

That difference in what is being acquired shows up directly in price.

How much does hygiene affect the multiple?

Meaningfully. Hygiene above roughly 30% of collections is read as recurring, transferable patient revenue that survives the owner’s departure, and practices in that range tend to attract a premium.

Can I find out what a specific DSO pays?

Not reliably, and you should distrust sources that claim to know. Buyers price deal by deal based on the practice, the market, their appetite and the competition.

Any multiple attached to a named buyer is generalized from limited data.

Does running a competitive process actually change the multiple?

Yes, and it changes the terms as well. A buyer approaching an owner directly has no competitive pressure and prices accordingly.

The same buyer bidding against several qualified others behaves differently, because their leverage has changed.

Should I improve my practice before selling, or sell now?

It depends on your timeline and what is holding the number down. Overhead reduction and shifting production toward associates and hygiene both raise EBITDA and the multiple applied to it, but they take 12 to 24 months to show up in defensible financials.

---

Sources

Market data and deal activity

1. Association of Dental Support Organizations. “About ADSO.” theadso.org
2. Becker’s Dental Review. “The largest DSOs headed into 2026.” beckersdental.com
3. Becker’s Dental Review. “200+ DSO affiliations in 2025: State-by-state breakdown.” beckersdental.com
4. Becker’s Dental Review. “69% of DSOs plan to boost acquisitions in 2026: Report.” beckersdental.com
5. Becker’s Dental Review. “The big trends driving DSO growth in 2026.” beckersdental.com
6. Becker’s Dental Review. “52 DSOs to know: 2026.” beckersdental.com
7. Group Dentistry Now. “DSO Deal Roundup — June 2026.” groupdentistrynow.com

Practice economics

8. ADA Health Policy Institute. “Trends in Dentists’ Income, Revenue and Hours Worked.” ada.org
9. ADA Health Policy Institute. “The State of the U.S. Dental Economy, Q1 2026 Update.” ada.org
10. ADA Health Policy Institute. “Dental Practice Research.” ada.org
11. ADA Health Policy Institute. “The Dental Care Market.” ada.org
12. NetSuite. “Dental Practice Overhead: Cost Breakdown, Benchmarks, and Insights.” netsuite.com

Consolidation, ownership and regulatory context

13. Congressional Research Service. “Private Equity Investments in Health Care: Selected Enforcement Issues.” congress.gov
14. Holland & Knight. “Q1 Recap on Proposed Legislation Affecting Healthcare Consolidation.” hklaw.com
15. Goodwin. “Antitrust & Competition Healthcare 1H 2026 Update.” goodwinlaw.com
16. ADA Health Policy Institute. “Practice Ownership Trends in Dentistry.” ada.org